Press release
Cardiac Biomarkers Market Size Worth $10.08 Billion by 2031 | Growing at 8.8% CAGR
Download Sample Report Here : https://www.meticulousresearch.com/download-sample-report/cp_id=6131
Rising Burden of Cardiovascular Diseases and Aging Population Boost Market Demand
The surge in cardiovascular diseases worldwide remains the most critical driver of the cardiac biomarkers market. Changing lifestyles characterized by unhealthy diets, physical inactivity, smoking, and excessive alcohol consumption have significantly increased the incidence of heart attacks and other heart-related conditions. According to the World Health Organization (WHO), cardiovascular diseases account for about 32% of all global deaths, with 85% resulting from heart attacks and strokes. In the United States alone, approximately 805,000 people suffer heart attacks annually, of which 605,000 are first-time incidents.
Additionally, the growing geriatric population plays a vital role in propelling market growth. Older adults are more susceptible to heart-related disorders due to age-related physiological changes. The WHO estimates that the number of people aged 60 years and older will rise to 1.4 billion by 2030 and reach 2.1 billion by 2050. As the elderly population expands, the demand for reliable diagnostic tools such as cardiac biomarkers is increasing, allowing for early disease detection and preventive healthcare interventions.
Awareness Programs Encourage Preventive Testing
Growing awareness about cardiovascular diseases through national and global campaigns has also contributed to the increased adoption of cardiac biomarkers. Initiatives such as The Heart Truth program by the U.S. National Heart, Lung, and Blood Institute (NHLBI) emphasize public education about heart disease risk factors and encourage preventive testing. With heart disease and stroke accounting for one in four deaths in the U.S., such awareness efforts have driven a greater emphasis on early detection using cardiac biomarkers. Additionally, healthcare organizations and governments are investing heavily in screening and education initiatives, prompting more people to undergo regular heart health assessments.
Browse in Depth : https://www.meticulousresearch.com/product/cardiac-biomarkers-market-6131
Market Trend: The Shift Toward Multi-Analyte Panels
An emerging trend shaping the cardiac biomarkers market is the adoption of multi-analyte panels. These panels simultaneously evaluate multiple biomarkers to provide a comprehensive assessment of cardiac health. By analyzing indicators related to inflammation, oxidative stress, and myocardial injury, healthcare providers can better stratify patients based on their risk of developing serious cardiac events. Multi-analyte testing not only enhances diagnostic accuracy but also facilitates early disease detection, allowing for timely medical intervention.
Moreover, monitoring several biomarkers enables healthcare professionals to track disease progression and treatment response over time. This integrated diagnostic approach ensures personalized care, minimizes misdiagnosis, and improves overall patient outcomes. As healthcare systems worldwide transition toward precision medicine, the use of such panels is expected to expand significantly in hospitals and diagnostic laboratories.
Why Are Cardiac Biomarkers Essential in Modern Cardiology?
Cardiac biomarkers are crucial because they allow early, accurate, and non-invasive detection of heart conditions. When the heart muscle is damaged-as occurs during a heart attack-specific proteins such as troponin and B-type natriuretic peptide (BNP) are released into the bloodstream. Measuring these biomarkers helps clinicians diagnose myocardial infarction, heart failure, or other cardiac abnormalities rapidly. This early detection enables timely intervention, reducing the risk of severe complications or death. In addition, these biomarkers play a vital role in monitoring treatment effectiveness and predicting patient prognosis, making them indispensable tools in cardiovascular care.
Integration of Biomarkers in Point-of-Care Testing Creates New Opportunities
A major growth opportunity for the cardiac biomarkers market lies in their integration into point-of-care (POC) testing devices. These portable diagnostic tools offer real-time results, which are particularly valuable in emergency situations where every minute counts. Rapid biomarker testing at the point of care allows clinicians to diagnose cardiac events such as heart attacks within minutes, ensuring faster treatment and improved patient survival rates.
Moreover, POC testing offers unmatched convenience. It can be performed in ambulances, clinics, or even at home, eliminating the need for time-consuming lab testing. This accessibility not only enhances patient satisfaction but also encourages regular monitoring for individuals at risk of heart disease. As healthcare moves toward decentralization, the demand for quick, accurate, and user-friendly biomarker-based POC devices is expected to surge.
Buy the Complete Report with an Impressive Discount: https://www.meticulousresearch.com/view-pricing/1448
Dominant Segments and Regional Insights
In 2024, the troponin segment dominated the global cardiac biomarkers market, accounting for more than half of total revenue. Troponin's high sensitivity and specificity in detecting myocardial infarction make it the preferred biomarker in cardiac diagnostics. Meanwhile, the B-type natriuretic peptide (BNP) segment is projected to record the highest growth rate during the forecast period, driven by rising heart failure cases and advancements in BNP assay technologies.
Among end users, laboratory testing remains the dominant segment due to the availability of advanced testing equipment, skilled personnel, and increasing emphasis on accurate early diagnosis. However, point-of-care testing is rapidly gaining momentum, especially in emergency and outpatient settings.
Regionally, North America held the largest market share in 2024, driven by high cardiovascular disease prevalence, a growing elderly population, and a well-established healthcare infrastructure. The U.S. remains a key contributor to regional dominance due to advanced diagnostic systems and strong awareness initiatives. On the other hand, Asia-Pacific is emerging as the fastest-growing region. Increasing urbanization, changing lifestyles, and expanding healthcare access in countries such as China and India are fueling demand for cardiac biomarker testing.
Competitive Landscape and Future Outlook
The cardiac biomarkers market is highly competitive, with major players such as Abbott Laboratories, F. Hoffmann-La Roche Ltd., Siemens Healthineers AG, Thermo Fisher Scientific, and QuidelOrtho Corporation leading innovation. Recent product launches, FDA approvals, and technological advancements are further strengthening their market presence. For instance, in 2024, Siemens Healthineers received FDA approval for its Atellica IM high-sensitivity troponin I test, while Roche Diagnostics India launched a point-of-care NT-proBNP test for diabetes and heart failure screening.
Looking ahead, the cardiac biomarkers market is poised for significant growth as healthcare systems worldwide prioritize early detection, preventive care, and personalized medicine. Technological innovations, combined with a rising global health awareness, will continue to drive the adoption of these essential diagnostic tools across hospitals, laboratories, and home healthcare settings.
Related Reports:
Biomarkers Market : https://www.meticulousresearch.com/product/biomarkers-market-5869
Cardiac Pacemaker Devices Market: https://www.meticulousresearch.com/product/cardiac-pacemaker-devices-market-3568
About Us:
We are a trusted research partner for leading businesses worldwide, empowering Fortune 500 organizations and emerging enterprises with actionable market intelligence tailored to drive revenue transformation and strategic growth. Our insights reveal forward-looking revenue opportunities, providing our clients with a competitive edge through a diverse suite of research solutions-syndicated reports, custom research, and direct analyst engagement.
Each year, we conduct over 300 syndicated studies and manage 60+ consulting engagements across eight key industry sectors and 20+ geographic markets. With a focus on solving the complex challenges facing global business leaders, our research enables informed decision-making that propels sustainable growth and operational excellence. We are dedicated to delivering high-impact solutions that transform business performance and fuel innovation in the competitive global marketplace.
Contact Us:
Meticulous Market Research Pvt. Ltd.
1267 Willis St, Ste 200 Redding,
California, 96001, U.S.
Email- sales@meticulousresearch.com
USA: +1-646-781-8004
Europe: +44-203-868-8738
APAC: +91 744-7780008
Visit Our Website: https://www.meticulousresearch.com/
For Latest Update Follow Us:
LinkedIn- https://www.linkedin.com/company/meticulous-research
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Cardiac Biomarkers Market Size Worth $10.08 Billion by 2031 | Growing at 8.8% CAGR here
News-ID: 4209218 • Views: …
More Releases from Meticulous Research®
Metagenomics Market to Reach $7.78 Billion by 2032 | Growing at 15.8% CAGR
Growing Market Outlook
The global metagenomics market is witnessing remarkable growth, driven by advancements in genomic research, automation, and the expanding scope of sequencing technologies. Valued at $2.43 billion in 2024, the market is projected to reach $7.78 billion by 2032, growing at a compound annual growth rate (CAGR) of 15.8% from 2025 to 2032. This strong growth is supported by falling sequencing costs, increased emphasis on agricultural genomics, and the…
Polymer Additive Manufacturing Market Size Worth $36.19 Billion by 2031 | Growin …
The global Polymer Additive Manufacturing Market has witnessed remarkable growth in recent years. Valued at $11.95 billion in 2023, the market is projected to grow from $13.55 billion in 2024 to $36.19 billion by 2031, at a strong CAGR of 15.1% during the forecast period (2024-2031). This expansion is largely attributed to the numerous advantages of polymer additive manufacturing (AM), including cost efficiency, design flexibility, and sustainability. The technology is…
Cytogenetics Market by Size, Share, Forecasts, & Trends Analysis
The global cytogenetics market was valued at USD 2.6 billion in 2023 and is projected to reach USD 5.5 billion by 2031, growing from an estimated USD 2.9 billion in 2024 at a CAGR of 9.6% during the forecast period. This strong growth trajectory is driven by the increasing focus on preventive healthcare, the rising prevalence of genetic disorders, the aging population, and the growing demand for early diagnosis of…
Ketto Fruits Market Set to Reach $82.95 Billion by 2032 Amid Rising Health Aware …
Ketto Fruits Market Size and Growth Outlook
The global Ketto fruits market was valued at USD 51.7 billion in 2024 and is projected to reach USD 82.95 billion by 2032, growing from an estimated USD 54.74 billion in 2025 at a CAGR of 6.1% during the forecast period (2025-2032). The growing popularity of Kettogenic diets, increasing consumer focus on health and wellness, and rising demand for natural and organic products are…
More Releases for Cardiac
Cardiac Resynchronization Therapy: Driving Innovation and Transforming Global Ca …
London, UK - August 2025 | Strategic Revenue Insights Inc. The global cardiac resynchronization therapy (CRT) market is emerging as one of the most crucial sectors in cardiovascular healthcare, offering life-saving solutions for patients with heart failure and conduction abnormalities. CRT devices, including pacemakers and defibrillators, are designed to restore synchronized heart contractions, significantly improving patient survival rates and quality of life. With rising cardiovascular disease prevalence worldwide, CRT has…
Mobile Cardiac Telemetry Systems Market Redefining Remote Cardiac Monitoring
"In recent years, the global Mobile Cardiac Telemetry Systems Market has witnessed a dynamic shift, influenced by changing consumer preferences, technological advancements, and a growing emphasis on sustainability. The Research report on Mobile Cardiac Telemetry Systems Market presents a complete judgment of the market through strategic insights on future trends, growth factors, supplier landscape, demand landscape, Y-o-Y growth rate, CAGR, pricing analysis. It also provides and a lot…
Ambulatory Cardiac Monitoring Devices Market: Revolutionizing Cardiac Care
In the rapidly evolving landscape of healthcare, the Ambulatory Cardiac Monitoring Devices Market stands out as a beacon of innovation and progress. These devices, including ECG devices, Holter monitors, event monitors, implantable loop recorders, and mobile cardiac telemetry, have become indispensable tools for healthcare professionals in managing and diagnosing cardiac conditions. As heart-related issues continue to afflict millions globally, the demand for advanced cardiac monitoring solutions is on the rise.
Request…
Cardiac Monitoring & Cardiac Rhythm Management Devices Market - Precision Monito …
Newark, New Castle, USA: The "Cardiac Monitoring & Cardiac Rhythm Management Devices Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Cardiac Monitoring & Cardiac Rhythm Management Devices…
Cardiac Monitoring & Cardiac Rhythm Management Device Market
According to a new market research report published by Global Market Estimates, the Global Cardiac Monitoring & Cardiac Rhythm Management Devices Market is expected to grow at a CAGR of 3.88% during the forecast period. The increasing occurrence of dyslipidemia, hypertension, and rising demand for cardiac monitoring & cardiac rhythm management devices to save patients at a huge risk of cardiac arrest.
Browse 145 Market Data Tables and 119 Figures spread…
Global Cardiac Monitoring & Cardiac Rhythm Management Market Insights, Forecast
Cardiac monitoring (CM) devices help in continuous examination of a patient’s cardiac activity. Cardiac rhythm management (CRM) devices maintain normal cardiac rhythm in patients suffering from rate and rhythm disorders of the heart. These devices play a crucial role in the treatment of serious cardiac disorders, including heart failure, atrial fibrillation, atrial flutter, indications of recent heart attack, coronary ischemia, lack of oxygen supply to cardiac muscles, effects of drugs,…
